Doximity, Inc. (DOCS) – What Are Investment Firms Thinking About This Stock?

Shares of Doximity, Inc. (NYSE:DOCS) have received an average recommendation of “Hold” from the twenty-five analysts that are presently covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a sell recommendation, fourteen have given a hold recommendation and eight have assigned a buy recommendation to the company. The average 12 month price target among brokers that have covered the stock in the last year is $30.73.

A number of analysts recently commented on DOCS shares. Needham & Company LLC reaffirmed a “buy” rating and issued a $41.00 price target on shares of Doximity in a research note on Friday, August 7th. Evercore set a $35.00 price target on Doximity in a research report on Tuesday, September 29th. BMO Capital Markets reissued a “market perform” rating and issued a $30.00 price objective on shares of Doximity in a research note on Friday, August 7th. Barclays lifted their price target on shares of Doximity from $20.00 to $27.00 and gave the company an “equal weight” rating in a report on Friday, August 21st. Finally, Raymond James Financial reiterated an “outperform” rating and issued a $38.00 target price on shares of Doximity in a research report on Friday.

Doximity Trading Down 2.2%

DOCS stock opened at $30.81 on Monday. The stock’s fifty day simple moving average is $26.75 and its two-hundred day simple moving average is $23.63. Doximity has a 1-year low of $17.15 and a 1-year high of $71.37. The stock has a market cap of $5.49 billion, a P/E ratio of 34.62, a P/E/G ratio of 24.64 and a beta of 1.22.

Doximity (NYSE:DOCS) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.29 EPS for the quarter, beating the consensus estimate of $0.16 by $0.13. The company had revenue of $156.62 million during the quarter. Doximity had a net margin of 25.48% and a return on equity of 18.06%. Doximity’s revenue was up 7.3% on a year-over-year basis. During the same period in the prior year, the firm posted $0.36 EPS. As a group, analysts forecast that Doximity will post 0.74 earnings per share for the current fiscal year.

Insider Buying and Selling at Doximity

In other news, Director Timothy Cabral sold 7,500 shares of the business’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $39.11, for a total value of $293,325.00. Following the sale, the director directly owned 3,221 shares in the company, valued at $125,973.31. The trade was a 69.96% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Phoebe Yang sold 1,290 shares of the company’s stock in a transaction dated Wednesday, September 30th. The shares were sold at an average price of $26.71, for a total transaction of $34,455.90. Following the sale, the director owned 24,744 shares in the company, valued at $660,912.24. This represents a 4.96% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 19,250 shares of company stock valued at $613,855. Corporate insiders own 31.80% of the company’s stock.

Institutional Trading of Doximity

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Carmignac Gestion raised its stake in Doximity by 127.8% in the first quarter. Carmignac Gestion now owns 4,311,997 shares of the company’s stock worth $100,480,000 after buying an additional 2,418,971 shares in the last quarter. Wellington Management Group LLP increased its position in Doximity by 24.7% during the 2nd quarter. Wellington Management Group LLP now owns 3,135,113 shares of the company’s stock valued at $65,022,000 after buying an additional 621,464 shares in the last quarter. Quantinno Capital Management LP boosted its holdings in Doximity by 420.5% in the first quarter. Quantinno Capital Management LP now owns 140,345 shares of the company’s stock worth $3,270,000 after acquiring an additional 113,380 shares in the last quarter. Royal Bank of Canada raised its position in shares of Doximity by 28.4% in the 1st quarter. Royal Bank of Canada now owns 206,282 shares of the company’s stock valued at $4,806,000 after purchasing an additional 45,618 shares during the last quarter. Finally, Whittier Trust Co. of Nevada Inc. boosted its stake in Doximity by 32,406.0% in the 1st quarter. Whittier Trust Co. of Nevada Inc. now owns 97,843 shares of the company’s stock worth $2,256,000 after purchasing an additional 97,542 shares in the last quarter. 87.19% of the stock is owned by hedge funds and other institutional investors.

Key Doximity News

Here are the key news stories impacting Doximity this week:

• Positive Sentiment: Doximity extended its 13-year alliance with U.S. News, supporting physician searches, appointment booking and hospital rankings. The partnership could reinforce user engagement and patient-access offerings. Doximity Deepens U.S. News Alliance to Improve Patient Access to Care
• Neutral Sentiment: Doximity will release fiscal 2027 second-quarter results on November 5, giving investors the next major opportunity to assess growth, advertising trends and management’s outlook. Doximity to Release Fiscal 2027 Second Quarter Results on November 5, 2026
• Negative Sentiment: Several law firms publicized a securities-fraud class action against Doximity and certain individuals, including co-founder and former Chief Strategy Officer Nate Gross. The allegations reportedly concern statements that Doximity could gain market share while older advertising formats were losing ground to programmatic and social-media competitors; the claims have not been established in court.
• Negative Sentiment: Investors who purchased DOCS shares between August 8, 2024 and May 13, 2026 are being reminded that November 16, 2026 is the deadline to seek appointment as lead plaintiff. Repeated announcements from Robbins Geller, SBS Law, Kaplan Fox, Rosen, Pomerantz, Bronstein Gewirtz Grossman and other firms increase the visibility of the legal overhang and could weigh on sentiment. DOCS Investor Alert

About Doximity

Doximity, Inc operates a digital platform designed for U.S. medical professionals. Its network enables physicians, nurse practitioners, physician assistants and other healthcare providers to connect with colleagues, exchange clinical information and access professional resources.

The company offers tools for telehealth and care coordination, including video and phone-based communication services, as well as digital faxing and secure messaging capabilities. Doximity also provides medical news and research content tailored to healthcare professionals.

Doximity generates additional business through recruiting and marketing solutions that help healthcare organizations reach clinicians and promote employment opportunities, services and products.